Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01671358 · ClinicalTrials.gov registry record
Comparison of Bacterial Contamination Rates Between Isolation and Non-isolation Rooms
A clinical trial of Methicillin-resistant Staphylococcus Aureus, sponsored by West Virginia University.
- Completed
- Registry status
- 400
- Enrollment target
- 1
- Study location
NCT01671358 is a study of Methicillin-resistant Staphylococcus Aureus that has completed, run by West Virginia University. The registered enrollment target is 400 participants, below the 15,825-participant average among 5 other Methicillin-resistant Staphylococcus Aureus trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01671358, a study of Methicillin-resistant Staphylococcus Aureus, has completed, sponsored by West Virginia University.
- COMPLETED
- Registry status
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is to determine if medication cabinets located outside of isolation rooms in hospitals and their contents, particularly medications and the delivery folders are at a higher risk of having harmful bacteria on them.
Conditions Studied
Study Locations (1)
West Virginia
- West Virginia University Hospitals - Morgantown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2012-08 |
| Est. Completion | 2013-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01671358
The ClinicalTrials.gov registry entry for NCT01671358 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 15,825-participant average among 5 other Methicillin-resistant Staphylococcus Aureus trials with a reported enrollment target (97% lower). The listed sponsor is West Virginia University, which has 122 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Methicillin-resistant Staphylococcus Aureus appearing as the primary indexed condition, and to 0 interventions.
NCT01671358 reports 1 study location spanning 1 distinct geographic area - top geographies include West Virginia.
Frequently Asked Questions
What is clinical trial NCT01671358 about?
NCT01671358 is a clinical study titled "Comparison of Bacterial Contamination Rates Between Isolation and Non-isolation Rooms". This study is to determine if medication cabinets located outside of isolation rooms in hospitals and their contents, particularly medications and the delivery folders are at a higher risk of having harmful bacteria on them.
What is the current status of trial NCT01671358?
This trial is currently completed. The enrollment target is 400 participants. The study started on 2012-08. Estimated completion is 2013-06.
What conditions does trial NCT01671358 study?
This clinical trial studies the following conditions: Methicillin-resistant Staphylococcus Aureus.
Who is sponsoring clinical trial NCT01671358?
This trial is sponsored by West Virginia University, which has 122 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01671358 being conducted?
This trial has 1 study location across West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Methicillin-resistant Staphylococcus Aureus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
PMT for MDRO Decolonization
RECRUITING · Phase 2
-
Trimethoprim-sulfamethoxazole vs. Clindamycin for the Treatment of Children With Invasive MRSA Infections
RECRUITING · Phase 4
-
Risk Factors for Early Infant Colonization With Methicillin-Resistant Staphylococcus Aureus
COMPLETED
-
Cluster Randomized Trial of Hospitals to Assess Impact of Targeted Versus Universal Strategies to Reduce Methicillin-resistant Staphylococcus Aureus (MRSA) in Intensive Care Units (ICUs)
COMPLETED · NA
-
Primary Care Management of Community-Acquired, Methicillin-Resistant Staphylococcus Aureus (CA-MRSA) Infections
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.